Results for re im translation from Czech to English

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Czech

English

Info

Czech

title: re: [im] Čtit 08 (srpen '07)

English

pages: [1]

Last Update: 2018-02-13
Usage Frequency: 1
Quality:

Czech

u pacientů, u kterých zpočátku nebyla provedena reperfúze, byla incidence úmrtí/ re- im k 30. dni

English

the

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Czech

primárním cílovým parametrem účinnosti byl ukazatel složený z úmrtí a opakovaného infarktu myokardu (re-im) v průběhu 30 dnů od randomizace.

English

the primary adjudicated endpoint was a composite of death and recurrent mi (re-mi) within 30 days of randomisation.

Last Update: 2017-04-26
Usage Frequency: 3
Quality:

Czech

v předem určené skupině, kde byl porovnáván fondaparinux s ufh (pacienti, kteří podstoupili primární pci (58,5 %), pacienti léčení fibrin-specifickými trombolytiky (13 %), pacienti léčení fibrin-nespecifickými trombolytiky (2,6 %) a pacienti bez reperfúzní terapie (25,9 %) nebyl zaznamenán statisticky významný rozdíl mezi účinkem fondaparinuxu a ufh na incidenci úmrtí/re-im k 30. dni: incidence 8,3 % pro fondaparinux a 8,7 % pro ufh (poměr rizik 0,94; 95 % is, 0,79, 1,11 p = 0,460).

English

in the predefined stratum comparing fondaparinux to ufh (patients treated with primary pci (58.5%), fibrin-specific lytics (13%), non-fibrin-specific lytics (2.6%) and no reperfusion (25.9%), the effects of fondaparinux and ufh on the incidence of death/re-mi at day 30 were not statistically different: respectively, 8.3% vs 8.7% (hazard ratio 0.94, 95% ci, 0.79, 1.11 p = 0.460).

Last Update: 2017-04-26
Usage Frequency: 4
Quality:

Some human translations with low relevance have been hidden.
Show low-relevance results.

Get a better translation with
8,797,666,255 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK